Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

703 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Tech-Ticker Issue 50: October 2023

    To regulate or not to regulate, that is the question. But there are no easy answers. This edition of the tech-ticker covers global AI
    IndiaTechnology
    Ikigai Law
    Ikigai Law
  • Article

    European Commission Approval To Rituximab Is First Biologic Treatment For A Rare Autoimmune Disease

    These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
Article

Suspension Of Fenspiride Medicines Due To Potential Risk Of Heart Rhythm Problems

On January 15, 2019 EMA's Pharmacovigilance Risk Assessment Committee recommended an EU-wide suspension of fenspiride medicines due to the risk of QT prolongation and torsades de pointes ...
European UnionFood, Drugs, Healthcare, Life Sciences
S&A Law Offices
S&A Law Offices
  • Video

    Webinar: Global Contract Management And Process Improvements

    Nexdigm (SKP) is hosting a webinar focusing on the efficiencies and business process improvement that a good Contract Management System can offer your company.
    GlobalCorporate/Commercial Law
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    WHO Launched A Joint Pilot Project With USFDA To Accelerate Access To HIV Medicines

    The FDA-reviewed products are currently being used to treat over 14 million HIV patients globally.
    GlobalFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    COMPAT Directs Re-Consideration Of Matter Against Director General Of Health Services & Others

    COMPAT by its order dated March 1, 2016 has set-aside the decision of CCI whereby CCI has refused to order investigation against the Director General Health Services...
    IndiaAntitrust/Competition Law
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    After Banning Manufacturing, Sale And Distribution Of Antibody Detecting Rapid Diagnostic Tests For The Diagnosis Of Malaria, The Health Ministry Now Bans Its Import Too

    On October 30, 2018, the Ministry of Health and Family Welfare (MoHFW) banned the import of Antibody Detecting Rapid Diagnostic Tests (ADRDTs) used for routine diagnosis of Malaria.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    ASCI Releases Guidelines For Usage Of Awards And Rankings In Healthcare Advertisements

    On January 20, 2020, the Advertisement Standards Council of India (ASCI) released guidelines for usage of Awards and Rankings in healthcare advertisements, which came into force from 1st February...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    CCI Approves The Proposed Combination Of GSK And Pfizer's Consumer Healthcare Products Into A New JV Co.

    On May 22, 2019, CCI approved the merger of certain consumer healthcare products of GlaxoSmithKline Plc. (‘GSK') and Pfizer Inc. (‘Pfizer', together with GSK
    IndiaFood, Drugs, Healthcare, Life Sciences
    AZB & Partners
    AZB & Partners
  • Article

    Developing Biosimilars In India: Prescriptions And Problems

    In India, access to health care facilities is still limited to a very small percentage of population owing mostly to unavailability of affordable drugs and treatment.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    EMA Restricts The Use Of Multiple Sclerosis Drug ‘Lemtrada' While Review Is Ongoing

    Symptoms of immune activation may occur up to 4 years after the start of treatment.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Food & Pharma Flash - July 2013

    AIOCD has decided to move the SC against the DPCO 2013.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    Government Proposes Second Draft Amendment Of Clinical Establishment Rules, 2019

    Reported draft notification on revised Rules is based on recommendations of a panel set up by the ministry on August 04, 2018.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Health Trade License

    With the improvement in the ease of doing business ranking, India is becoming the increasingly becoming the popular destination for establishment of business opportunities.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Healthcare | September And October 2024 - Case Laws

    The Kerala High Court, in the case of Celinamol Mathew vs. State of Kerala1, has opined that nurses in Government service and in private hospitals should also get protection...
    IndiaFood, Drugs, Healthcare, Life Sciences
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    Increasing Instances Of Misleading Advertisements Of Products & Services From AYUSH And Herbal Medicines

    The Minister of State for the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy, in a written reply to a query from Lok Sabha, has stated that increasing number of misleading advertisements ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Video

    India's Attractiveness And Opportunities In Healthcare (Video)

    The supply-side shocks associated with the COVID-19 pandemic have highlighted the business risks associated with the concentration of supply from a single source.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Indian Council Of Medical Research Launched Vaccine Trial To Prevent Spread Of Tuberculosis

    On July 15, 2019, Indian Council of Medical Research (ICMR) has launched a vaccine trial (‘Trial') to prevent the occurrence of Tuberculosis (TB) among close contacts of TB patients.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Indian Industry And Regulators Embrace The Digital Wave

    With reports stating that 75% of patients expect to use digital services in the future, the future of healthcare is in the online space.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Lead Exposure, A Possible Risk Factor Causing Alzheimer's Disease: ICMR

    On January 13, 2020, the Indian Council of Medical Research (ICMR) reported ‘Lead exposure' as a possible risk factor for causing Alzheimer's disease based on a study conducted at National...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Showing 101–120 of 703 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics